Caseware UK (AP4) 2025.0.111 2025.0.111 2025-12-312025-12-312026-05-062026-05-06false2025-01-01sale of healthcare packaging products33truetruefalse 14565745 2025-01-01 2025-12-31 14565745 2024-01-01 2024-12-31 14565745 2025-12-31 14565745 2024-12-31 14565745 c:Director1 2025-01-01 2025-12-31 14565745 c:Director2 2025-01-01 2025-12-31 14565745 d:CurrentFinancialInstruments 2025-12-31 14565745 d:CurrentFinancialInstruments 2024-12-31 14565745 d:Non-currentFinancialInstruments 2025-12-31 14565745 d:Non-currentFinancialInstruments 2024-12-31 14565745 d:CurrentFinancialInstruments d:WithinOneYear 2025-12-31 14565745 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 14565745 d:Non-currentFinancialInstruments d:AfterOneYear 2025-12-31 14565745 d:Non-currentFinancialInstruments d:AfterOneYear 2024-12-31 14565745 d:ShareCapital 2025-12-31 14565745 d:ShareCapital 2024-12-31 14565745 d:RetainedEarningsAccumulatedLosses 2025-12-31 14565745 d:RetainedEarningsAccumulatedLosses 2024-12-31 14565745 c:FRS102 2025-01-01 2025-12-31 14565745 c:Audited 2025-01-01 2025-12-31 14565745 c:FullAccounts 2025-01-01 2025-12-31 14565745 c:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 14565745 c:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 14565745 2 2025-01-01 2025-12-31 14565745 e:PoundSterling 2025-01-01 2025-12-31 iso4217:GBP xbrli:pure

Registered number: 14565745










OLIVER HEALTHCARE PACKAGING UK LIMITED










FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2025

 
OLIVER HEALTHCARE PACKAGING UK LIMITED
REGISTERED NUMBER: 14565745

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2025

2025
2024
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
271,228
775,646

Cash at bank and in hand
 5 
61,757
90,653

  
332,985
866,299

Creditors: amounts falling due within one year
 6 
(89,997)
(691,139)

Net current assets
  
 
 
242,988
 
 
175,160

Total assets less current liabilities
  
242,988
175,160

Creditors: amounts falling due after more than one year
 7 
-
(5,675)

  

Net assets
  
242,988
169,485


Capital and reserves
  

Called up share capital 
  
1,000
1,000

Profit and loss account
  
241,988
168,485

  
242,988
169,485


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 6 May 2026.




Michael James Benevento
Douglas Allen Kramer
Director
Director

The notes on pages 2 to 5 form part of these financial statements.

Page 1

 
OLIVER HEALTHCARE PACKAGING UK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1.


General information

The principle activity of the company during the year has been the sale of healthcare packaging products.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Financial Reporting Standard 102 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
∙the requirements of Section 33 Related Party Disclosures paragraph 33.7.

This information is included in the consolidated financial statements of Oliver Healthcare Packaging Company as at 31/12/2025 and these financial statements may be obtained from 445 6th St NW, Grand Rapids, MI 49504, United States.

 
2.3

Going concern

The directors have assessed the Company's ability to continue as a going concern and have a reasonable expectation that the company has adequite resource to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statments.

  
2.4

Revenue

Turnover is measured at the fair value of the consideration received or receivable and represents the amount receivable for services rendered, net of returns, discounts and rebates allowed by the company.

The company earns commission from other manufacturers in relation to the sale of products designed by the company. Commission income is recognised on an accruals basis in accordance with the substance of the relevant agreement.

 
2.5

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 2

 
OLIVER HEALTHCARE PACKAGING UK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.6

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.7

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
∙The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
∙Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

In December 2021, the OECD issued model rules for a new global minimum tax framework (Pillar Two) applicable for multinational enterprise groups with global revenue over €750m. The legislation implementing the rules in the UK was substantively enacted on 20 June 2023 and first has effect for the Company for the year ended 31 December 2024. The Company has applied the exemption under FRS 102 in relation to accounting for deferred tax assets and liabilities arising from the implementation of the Pillar Two model rules.

A current tax expense has not been recorded in respect of Pillar Two income taxes in this Company for the year ending 31 December 2025 due to the transitional safe harbor rules applying.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 3

 
OLIVER HEALTHCARE PACKAGING UK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 3 (2024 - 3).


4.


Debtors

2025
2024
£
£


Amounts owed by group undertakings
239,458
763,409

Other debtors
31,039
10,367

Deferred taxation
731
1,870

271,228
775,646


Amounts owed by group undertakings are unsecured, interest free and repayable on demand.


5.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
61,757
90,653

61,757
90,653


Page 4

 
OLIVER HEALTHCARE PACKAGING UK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

6.


Creditors: Amounts falling due within one year

2025
2024
£
£

Amounts owed to group undertakings
-
481,189

Other taxation and social security
8,757
16,972

Other creditors
-
17,346

Accruals and deferred income
81,240
175,632

89,997
691,139


Amounts owed to group undertakings are unsecured, interest free and repayable on demand.


7.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Accruals and deferred income
-
5,675

-
5,675



8.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £30,671 (2024 - £30,188). All contributions have been fully paid as at the balance sheet date, and their are no outstanding liabilities. 


9.


Controlling party

The immediate parent undertaking and controlling party is Oliver Healthcare Packaging Company, a company incorporated in the USA. There is no one ultimate controlling party due to the the Group Structure.


10.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2025 was unqualified.

The audit report was signed on 6 May 2026 by Suzanne Villiers (Senior statutory auditor) on behalf of AAB Group Accountants Limited.

Page 5